» Articles » PMID: 23127296

Exaggerated Neurobiological Sensitivity to Threat As a Mechanism Linking Anxiety with Increased Risk for Diseases of Aging

Overview
Date 2012 Nov 7
PMID 23127296
Citations 69
Authors
Affiliations
Soon will be listed here.
Abstract

Anxiety disorders increase risk for the early development of several diseases of aging. Elevated inflammation, a common risk factor across diseases of aging, may play a key role in the relationship between anxiety and physical disease. However, the neurobiological mechanisms linking anxiety with elevated inflammation remain unclear. In this review, we present a neurobiological model of the mechanisms by which anxiety promotes inflammation. Specifically we propose that exaggerated neurobiological sensitivity to threat in anxious individuals may lead to sustained threat perception, which is accompanied by prolonged activation of threat-related neural circuitry and threat-responsive biological systems including the hypothalamic-pituitary-adrenal (HPA) axis, autonomic nervous system (ANS), and inflammatory response. Over time, this pattern of responding can promote chronic inflammation through structural and functional brain changes, altered sensitivity of immune cell receptors, dysregulation of the HPA axis and ANS, and accelerated cellular aging. Chronic inflammation, in turn, increases risk for diseases of aging. Exaggerated neurobiological sensitivity to threat may thus be a treatment target for reducing disease risk in anxious individuals.

Citing Articles

Trajectory of peripheral inflammation during index ECT in association with clinical outcomes in treatment-resistant depression.

Hough C, Kruse J, Espinoza R, Brooks 3rd J, Congdon E, Norris V Brain Behav Immun Health. 2025; 43():100925.

PMID: 39834556 PMC: 11743860. DOI: 10.1016/j.bbih.2024.100925.


Addressing Mental Health in Rural Settings: A Narrative Review of Blueberry Supplementation as a Natural Intervention.

Venable K, Lee C, Francis J Nutrients. 2024; 16(20).

PMID: 39458533 PMC: 11510281. DOI: 10.3390/nu16203539.


Role of Inflammation in Depressive and Anxiety Disorders, Affect, and Cognition: Genetic and Non-Genetic Findings in the Lifelines Cohort Study.

Giollabhui N, Slaney C, Hemani G, Foley E, van der Most P, Nolte I Res Sq. 2024; .

PMID: 39149475 PMC: 11326402. DOI: 10.21203/rs.3.rs-4379779/v1.


Major depression is not associated with higher myocardial infarction rates: insights from a large database.

Meskal S, Gill M, Movahed M, Hashemzadeh M, Hashemzadeh M Future Cardiol. 2024; 20(11-12):619-625.

PMID: 39136382 PMC: 11520533. DOI: 10.1080/14796678.2024.2387939.


Associations of Anxiety Symptoms With 6-Year Blood Pressure Changes and Incident Hypertension: Results From the Hispanic Community Health Study/Study of Latinos.

Rosas C, Pirzada A, Durazo-Arvizu R, Gallo L, Talavera G, Elfassy T Ann Behav Med. 2024; 58(7):488-497.

PMID: 38810223 PMC: 11185088. DOI: 10.1093/abm/kaae026.


References
1.
Sapolsky R, Romero L, Munck A . How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr Rev. 2000; 21(1):55-89. DOI: 10.1210/edrv.21.1.0389. View

2.
Kubzansky L, Kawachi I . Going to the heart of the matter: do negative emotions cause coronary heart disease?. J Psychosom Res. 2000; 48(4-5):323-37. DOI: 10.1016/s0022-3999(99)00091-4. View

3.
Fredrikson M, Furmark T . Amygdaloid regional cerebral blood flow and subjective fear during symptom provocation in anxiety disorders. Ann N Y Acad Sci. 2003; 985:341-7. DOI: 10.1111/j.1749-6632.2003.tb07092.x. View

4.
Pace T, Heim C . A short review on the psychoneuroimmunology of posttraumatic stress disorder: from risk factors to medical comorbidities. Brain Behav Immun. 2010; 25(1):6-13. DOI: 10.1016/j.bbi.2010.10.003. View

5.
Yin W, Chen J, Jen H, Chiang M, Huang W, Feng A . Independent prognostic value of elevated high-sensitivity C-reactive protein in chronic heart failure. Am Heart J. 2004; 147(5):931-8. DOI: 10.1016/j.ahj.2003.11.021. View